| ZM 306416 |
| N-(4-Chloro-2-fluorophenyl)-6,7-dimethoxy-4-quinazolinamine |
| (CAS 690206-97-4) |
 |
| Description： |
ZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, but also found to inhibit EGFR with IC50 of <10 nM.
IC50 Value: 0.67uM(for VEGFR); 0.33±0.08uM(for Src); 1.3±0.2 μM(for Abl) ZM-306416, a vascular endothelial growth factor receptor (VEGFR) antagonist, was identified as a potent inhibitor of EGFR function.
in vitro: 306416 was found to be very potent toward the EGFR kinase with an IC50 value lower than 10 nM, reaching our assay detection limit and confirming our result using the EGFRB assay. ZM-306416 exhibited inhibitory activity across all three kinases of the panel, yielding IC50 values of 0.33±0.08 μM for SRC, 0.33±0.04 μM for VEGFR1, and 1.3±0.2 μM for ABL kinases.
|
| Product No. |
KT01016 |
| Product Name |
ZM 306416 |
| Synonyms |
CB 676475 |
| Formal Name |
N-(4-Chloro-2-fluorophenyl)-6,7-dimethoxy-4-quinazolinamine |
| CAS Number |
690206-97-4 |
| Molecular Formula |
C16H13ClFN3O2 |
| Formula Weight |
333.74 |
| Formulation |
|
| Purity |
98%min |
| Stability |
1 year |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500. |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
SKLB1002
AZD9291
Cabozantinib (XL184, BMS-907351)
CO-1686
Regorafenib (BAY 73-4506)
|
|
